Top 10: Generieke geneesmiddelen o.b.v de vergoeding in 2024
- Raming voor de totale Zvw-populatie
- (1=1.000)
| 2020 | 2021 | 2022 | 2023 | 2024 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rang 2024 |
ATC-code (*) | Marktaandeel generiek | Marktaandeel generiek | Marktaandeel generiek | Marktaandeel generiek | Marktaandeel generiek | |||||
| 1 | N02AB03 Fentanyl | 6.344 | 13% | 19.007 | 41% | 23.310 | 47% | 35.460 | 65% | 34.697 | 67% |
| 2 | C07AB02 Metoprolol | 13.112 | 92% | 18.803 | 95% | 20.307 | 95% | 22.676 | 95% | 26.672 | 95% |
| 3 | A02BC02 Pantoprazol | 12.104 | 97% | 15.277 | 98% | 17.667 | 99% | 18.357 | 99% | 20.448 | 99% |
| 4 | A06AD65 Macrogol combinatiepreparaten | 17.375 | 74% | 17.358 | 72% | 17.492 | 72% | 18.300 | 75% | 19.854 | 76% |
| 5 | B01AE07 Dabigatranetexilaat | 582 | 2% | 19.153 | 69% | ||||||
| 6 | A10BA02 Metformine | 10.136 | 98% | 11.723 | 97% | 12.284 | 100% | 14.324 | 100% | 16.634 | 100% |
| 7 | N06BA04 Methylfenidaat | 10.799 | 58% | 13.274 | 67% | 15.392 | 69% | 14.541 | 64% | 16.084 | 66% |
| 8 | A10BB09 Gliclazide | 6.653 | 100% | 8.644 | 100% | 9.260 | 100% | 13.231 | 100% | 15.061 | 100% |
| 9 | A02BC01 Omeprazol | 9.377 | 63% | 8.873 | 66% | 9.872 | 74% | 12.975 | 85% | 14.658 | 87% |
| 10 | A10AB05 Insuline aspart | 30 | 0% | 10.187 | 26% | 13.462 | 33% | 13.633 | 34% | 14.396 | 36% |
| Overige generieken | 545.096 | 560.757 | 611.314 | 710.494 | 796.485 | ||||||
| Totaal | 631.024 | 683.904 | 750.360 | 874.573 | 994.143 | ||||||